Similar articles

• Designing sleeping sickness control.

  Kinoshita T. Kinoshita T. ACS Chem Biol. 2008 Oct 17;3(10):601-3. doi: 10.1021/cb800239p. ACS Chem Biol. 2008. PMID: 18928247
• Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.

  Smith TK, Crossman A, Brimacombe JS, Ferguson MA. Smith TK, et al. EMBO J. 2004 Nov 24;23(23):4701-8. doi: 10.1038/sj.emboj.7600456. Epub 2004 Nov 4. EMBO J. 2004. PMID: 15526036 Free PMC article.
• Carbohydrate-binding agents act as potent trypanocidals that elicit modifications in VSG glycosylation and reduced virulence in Trypanosoma brucei.

  Castillo-Acosta VM, Vidal AE, Ruiz-Pérez LM, Van Damme EJ, Igarashi Y, Balzarini J, González-Pacanowska D. Castillo-Acosta VM, et al. Mol Microbiol. 2013 Nov;90(4):665-79. doi: 10.1111/mmi.12359. Epub 2013 Oct 14. Mol Microbiol. 2013. PMID: 23926900
• The glycosylation of the variant surface glycoproteins and procyclic acidic repetitive proteins of Trypanosoma brucei.

  Mehlert A, Zitzmann N, Richardson JM, Treumann A, Ferguson MA. Mehlert A, et al. Mol Biochem Parasitol. 1998 Mar 1;91(1):145-52. doi: 10.1016/s0166-6851(97)00187-4. Mol Biochem Parasitol. 1998. PMID: 9574932 Review.
• Glycosyl phosphatidylinositol myristoylation in African trypanosomes.

  Werbovetz KA, Englund PT. Werbovetz KA, et al. Mol Biochem Parasitol. 1997 Mar;85(1):1-7. doi: 10.1016/s0166-6851(96)02820-4. Mol Biochem Parasitol. 1997. PMID: 9108544 Review. No abstract available.